Abstract
Fluorine magnetic resonance imaging ((19) F MRI) is a promising imaging technique for cancer diagnosis because of its excellent soft tissue resolution and deep tissue penetration, as well as the inherent high natural abundance, almost no endogenous interference, quantitative analysis, and wide chemical shift range of the (19) F nucleus. In recent years, scientists have synthesized various (19) F MRI contrast agents. By further integrating a wide variety of nanomaterials and cutting-edge construction strategies, magnetically equivalent (19) F atoms are super-loaded and maintain satisfactory relaxation efficiency to obtain high-intensity (19) F MRI signals. In this review, the nuclear magnetic resonance principle underlying (19) F MRI is first described. Then, the construction and performance of various fluorinated contrast agents are summarized. Finally, challenges and future prospects regarding the clinical translation of (19) F MRI nanoprobes are considered. This review will provide strategic guidance and panoramic expectations for designing new cancer theranostic regimens and realizing their clinical translation.